Cited by 15Childhood Cancer Survivors' Quality of LifeCancer survivorship and careAcute Lymphoblastic Leukemia research

The cumulative burden of self‐reported, clinically relevant outcomes in long‐term childhood cancer survivors and implications for survivorship care: A DCCSS LATER study

Open access
Streefkerk, Nina, Teepen, Jop C., Feijen, Elizabeth A. M., Jóźwiak, Katarzyna, van der Pal, Helena J. H., Ronckers, Cecile M., De Vries, Andrica C. H., Van der Heiden‐van Der Loo, Margriet +18 more·2024·Cancer

Abstract

Background: The aim of this study is to evaluate how cumulative burden of clinically relevant, self‐reported outcomes in childhood cancer survivors (CCSs) compares to a sibling control group and to explore how the burden corresponds to levels of care proposed by existing risk stratifications. Methods: The authors invited 5925 5‐year survivors from the Dutch Childhood Cancer Survivor Study (DCCSS LATER) cohort and their 1066 siblings to complete a questionnaire on health outcomes. Health outcomes were validated by self‐reported medication use or medical record review. Missing data on clinically relevant outcomes in CCSs for whom no questionnaire data were available were imputed with predictive mean matching. We calculated the mean cumulative count (MCC) for clinically relevant outcomes. Furthermore, we calculated 30‐year MCC for groups of CCSs based on primary cancer diagnosis and treatment, ranked 30‐year MCC, and compared the ranking to levels of care according to existing risk stratifications. Results: At median 18.5 years after 5‐year survival, 46% of CCSs had at least one clinically relevant outcome. CCSs experienced 2.8 times more health conditions than siblings (30‐year MCC = 0.79; 95% confidence interval [CI], 0.74–0.85 vs. 30‐year MCC = 0.29; 95% CI, 0.25–0.34). CCSs’ burden of clinically relevant outcomes consisted mainly of endocrine and vascular conditions and varied by primary cancer type. The ranking of the 30‐year MCC often did not correspond with levels of care in existing risk stratifications. Conclusions: CCSs experience a high cumulative burden of clinically relevant outcomes that was not completely reflected by current risk stratifications. Choices for survivorship care should extend beyond primary tumor and treatment parameters, and should consider also including CCSs’ current morbidity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.35148

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Streefkerk, N., Teepen, J. C., Feijen, E. A. M., Jóźwiak, K., van der Pal, H. J. H., Ronckers, C. M., De Vries, A. C. H., Van der Heiden‐van Der Loo, M., Hollema, N., van den Berg, M., Loonen, J., Grootenhuis, M. A., Bresters, D., Versluys, A. B., van Dulmen‐den Broeder, E., van den Heuvel‐Eibrink, M. M., van Leeuwen, F. E., Neggers, S. J. C. M. M., Van Santen, H. M., Hawkins, M., Hauptmann, M., Yoneoka, D., Korevaar, J. C., Tissing, W. J. E., Kremer, L. C. M., & DCCSS LATER Study Group
Affiliations
  • Emma Kinderziekenhuis (NL)
  • Princess Máxima Center (NL)
  • The Netherlands Cancer Institute (NL)
  • Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands
  • St. Antonius Ziekenhuis (NL)
  • Department of Pediatric Oncology/Hematology Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands
  • Radboud University Medical Center (NL)
  • Department of Epidemiology and Biostatistics The Netherlands Cancer Institute Amsterdam The Netherlands
  • Erasmus MC (NL)
  • University of Birmingham (GB)
  • St. Luke's International University (JP)
  • Netherlands Institute for Health Services Research (NL)
  • University Medical Center Groningen (NL)
  • University Medical Center Utrecht (NL)
Corresponding author
Kremer, Leontien C. M.
Venue
Cancer
Publisher
Wiley
Published
2023-12-15
Volume
130
Issue
8
Pages
1349-1358
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W4389777783
Cited by
15
References
15
Citations by year
2026: 7 · 2025: 5 · 2024: 3
FWCI
5.52
Type
journal article
Language
en
Open access
Locations
  • Cancer (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
  • CHILDREN with CANCER UK (20-335)
  • Brain Tumour Charity (GN-000624)
  • KWF Kankerbestrijding (UVA2014‐6805, UVA2012-5517)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Acute Lymphoblastic Leukemia research
Keywords
childhood cancer survivors, long-term follow-up, survivorship care, risk stratification, endocrine complications, vascular complications, siblings as controls, primary cancer type
MeSH terms
Cancer Survivors, Survivorship, Child, Humans, Neoplasms, Survivors, Self Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review